Records containing: Malignant Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2015-12-17A Phase I, Randomized, Open-label, Multi-center, Two Period Crossover Study to Investigate the Effect of Food on the Pharmacokinetics of a Single Oral Dose of RO5185426, Followed by Administration of 960 mg RO5185426 Twice Daily to BRAF V600E Positive Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2015-12-08A Phase I, Open-label, Excretion Balance, Pharmacokinetic and Metabolism Study After Single Oral Dose of 14C-labeled RO5185426 in Previously Treated and Untreated Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-10-30A Phase III, Double-Blind, Placebo-Controlled Study of Vemurafenib Versus Vemurafenib Plus GDC-0973 in Previously Untreated BRAF^600-Mutation Positive Patients With Unresectable Locally Advanced or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-10-05A Multi-center, Open-label, Study to Investigate the Pharmacokinetic Interaction of RO5185426 With a "Cocktail" of Five Probe Drugs for CYP450 Dependent Metabolism in Patients With Previously Treated and Untreated Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2015-08-26A Phase I, Randomized, Open-label, Multi-center, Multiple Dose Study to Investigate the Pharmacokinetics and Pharmacodynamics of RO5185426 Administered as 240 mg Tablets to Previously Treated BRAF V600E Positive Metastatic Melanoma Patients
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2015-08-19Evaluation of Dendritic Cells Transfected With Survivin, hTERT and p53 mRNA as a Treatment for Patients With Metastatic Breast Cancer or Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2015-08-07An Open-label, Pilot Study of RO5185426 in Previously Treated Metastatic Melanoma Patients With Brain Metastases
-
CLINICAL_TRIALS study record update · 2015-07-21A Phase II Study to Evaluate Safety and Efficacy of Combined Treatment With Ipilimumab and Intratumoral Interleukin-2 in Pretreated Patients With Stage IV Melanoma
-
CLINICAL_TRIALS study record update · 2015-06-11rIL-2 Activated Allogeneic Lymphocytes for the Induction of Graft Versus Tumor Effect (GVT) in Metastatic Solid Tumors
-
CLINICAL_TRIALS study record update · 2015-04-22Comparison of Video-based Versus Written Patient Education on Melanoma
-
CLINICAL_TRIALS study record update · 2015-03-19A Phase II Study of Lapatinib for the Treatment of Stage IV Melanoma Harboring ERBB4 Mutations
-
CLINICAL_TRIALS study record update · 2015-02-20A Phase 1, Open Label, Dose-escalation, Safety and Pharmacokinetic Study of MDX-1106 in Patients With Selected or Relapsed Malignancies
-
CLINICAL_TRIALS study record update · 2015-02-11An Open-Label, Single-arm, Multicenter Phase I Study of SCH 54031 (Pegylated Interferon Alfa-2b) as an Adjuvant Treatment in Japanese Patients With Malignant Melanoma (Protocol No. MK-4031 370 Also Known as SCH 54031, P08556)
-
CLINICAL_TRIALS study record update · 2014-12-11Long-term Outcome After Radical Lymph Node Dissection of Malignant Melanoma. Comparison Between Regional Versus General Anesthesia With Respect to Impact of Perioperative Immunoediting and Validation of New Potential Predictive Biomarkers
-
CLINICAL_TRIALS study record update · 2014-11-20A Phase II Study of Intratumoral Application of L19IL2 in Patients With Stage III/IV Melanoma.
-
CLINICAL_TRIALS study record update · 2014-11-05Trial With Telomerase Peptide Vaccine In Combination With Temozolomide in Patients With Advanced Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2014-09-05Phase II Trial of ONTAK With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-08-29ClinicalTrials.gov study NCT02223884
-
CLINICAL_TRIALS study record update · 2014-08-13A Phase I, Open-Label Study to Assess the Effect of Dosing AZD6244 HydSulfate in the Presence and Absence of Food in Patients With Advanced Solid Malignancies
-
CLINICAL_TRIALS study record update · 2014-06-25An Open-label Study to Assess the Anti-tumor Activity of Avastin in Combination With Fotemustine as First-line Therapy in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2014-06-05An Open-Label, Multicenter, Phase III Trial of ABI-007 vs Dacarbazine in Previously Untreated Patients With Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2014-02-27Phase II Study Incorporating Pegylated Interferon In the Treatment For Children With High-Risk Melanoma
-
CLINICAL_TRIALS study record update · 2013-12-30SciBase International Melanoma Pivotal Study
-
CLINICAL_TRIALS study record update · 2013-11-25Phase I/II Trial of Valproic Acid and Karenitecin for Metastatic Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2013-09-12A Multicentre, Dose Finding, Phase II Study of CP-4055 in Combination With Sorafenib in Patients With Metastatic Malignant Melanoma